Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. Symptoms include shortness of breath, chest tightness or pain, chronic coughing and trouble sleeping due to coughing or wheezing. The predisposing factors include family history, overweight, smoking, exposure to exhaust fumes or other types of pollution and exposure to occupational triggers, such as chemicals used in farming, hairdressing and manufacturing. Treatment includes inhaled corticosteroids, leukotriene modifiers, antihistamines and decongestants.
Place a direct purchase order on this report @ http://www.orbisresearch.com/contact/purchase/146142 .
Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Asthma – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Asthma (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 6, 16, 44, 36, 124, 25 and 2 respectively for Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 24 and 8 molecules, respectively for Asthma.
Asthma (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Request a sample of Asthma-Pipeline Review, H2 2016
– The pipeline guide provides a snapshot of the global therapeutic landscape of Asthma (Respiratory).
– The pipeline guide reviews pipeline therapeutics for Asthma (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Asthma (Respiratory) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Asthma (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Asthma (Respiratory)
Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Asthma (Respiratory).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Asthma (Respiratory) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Asthma – Companies Involved in Therapeutics Development
4D Pharma Plc
AB Science SA
Accolade Pharmaceuticals, LLC
Acorda Therapeutics, Inc.
Adamis Pharmaceuticals Corporation
Advinus Therapeutics Ltd
Afferent Pharmaceuticals, Inc.
Allergopharma GmbH & Co. KG
AnGes MG, Inc.
Antisense Therapeutics Limited
ARA Healthcare Pvt. Ltd.
Array BioPharma Inc.
ASIT biotech s.a.
Astellas Pharma Inc.
Asubio Pharma Co., Ltd.
Aurigene Discovery Technologies Limited
Axikin Pharmaceuticals, Inc.
Bioncotech Therapeutics SL
Biotec Pharmacon ASA
Boehringer Ingelheim GmbH
Cellular Biomedicine Group, Inc.
Celon Pharma Sp. z o.o.
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
Cumberland Pharmaceuticals, Inc.
Cynata Therapeutics Limited
Daiichi Sankyo Company, Limited
F. Hoffmann-La Roche Ltd.
Foresee Pharmaceuticals, LLC
Fountain Biopharma Inc.
Griffin Discoveries BV
Han Wha Pharma Co., Ltd.
Hydra Biosciences, Inc.
iCo Therapeutics Inc.
Infinity Pharmaceuticals, Inc.
INOXIA Lifesciences GmbH
Intech Biopharm Ltd
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Johnson & Johnson
Kissei Pharmaceutical Co., Ltd.
Kolltan Pharmaceuticals, Inc.
KPI Therapeutics, Inc.
Kyowa Hakko Kirin Co., Ltd.
Lead Discovery Center GmbH
LegoChem Biosciences, Inc
Ligand Pharmaceuticals, Inc.
Marinomed Biotechnologie GmbH
Merck & Co., Inc.
Mitsubishi Tanabe Pharma Corporation
Mycenax Biotech Inc.
NAL Pharmaceuticals Ltd.
NeoPharm Co., Ltd.
Ono Pharmaceutical Co., Ltd.
OPKO Health, Inc.
Orbis Biosciences Inc
Palatin Technologies, Inc.
Panacea Biotec Limited
Panmira Pharmaceuticals, LLC.
Paradigm Biopharmaceuticals Limited
Pieris Pharmaceuticals Inc
Pila Pharma AB
Prous Institute for Biomedical Research S.A.
Pulmagen Therapeutics LLP
Regeneron Pharmaceuticals Inc
ReveraGen BioPharma, Inc.
Rhizen Pharmaceuticals S.A.
Saje Pharma, LLC
Spring Bank Pharmaceuticals, Inc.
Stallergenes Greer plc
Sterna biologicals Gmbh & Co KG
Sumitomo Dainippon Pharma Co., Ltd.
Sun Pharma Advanced Research Company Ltd.
Sunovion Pharmaceuticals Inc.
Synermore Biologics Co Ltd
Syntrix Biosystems, Inc.
TaiwanJ Pharmaceuticals Co., Ltd.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.
The International Biotechnology Center (IBC) Generium
Therabron Therapeutics, Inc.
Theravance Biopharma, Inc.
United BioPharma, Inc.
Vectura Group Plc
Verona Pharma Plc
WhanIn Pharmaceutical Co., Ltd.
Yungjin Pharm. Co., Ltd.
Zambon Company S.p.A.
Browse the complete report @ http://www.orbisresearch.com/reports/index/asthma-pipeline-review-h2-2016 .
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: email@example.com